Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
Researchers from University of California, Moores Cancer Center publish new studies and findings in the area of anthrax vaccines
March 25th, 2008
New investigation results, 'A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system,' are detailed in a study published in Protein Expression and Purification. According to a study from the United States, "New generation anthrax vaccines have been actively explored with the aim of enhancing efficacies and decreasing undesirable side effects that could be caused by licensed vaccines. Targeting novel antigens and/or eliminating the requirements for multiple needle injections and adjuvants are major objectives in the development of new anthrax vaccines." "Using proteomics...
Source: Cancer Weekly (2008-03-25)
|
